Critical Therapeutics, Inc. (CRTX) Signs Definitive Agreement to Merge with Cornerstone BioPharma, Inc.  
5/2/2008 9:55:27 AM

LEXINGTON, Mass. and CARY, N.C.--(BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, today announced the signing of a definitive merger agreement. Cornerstone is a specialty pharmaceutical company focused on developing and commercializing prescription medications for respiratory disorders. The stock-for-stock transaction is targeted to close in the fourth quarter of 2008.